Teneligliptin CAS 760937-92-6 is a pharmaceutical drug for the treatment of type 2 diabetes mellitus. It belongs to the class of anti-diabetic drugs known as dipeptidyl peptidase-4 inhibitors or gliptins. Because of the unique J shaped or anchor locked domain structure, Teneligliptin 760937-92-6 could more potent inhibition of DPP 4 enzyme as compared to other drugs. We offer high quality Teneligliptin, which is more safe and effective.
Thera. Category: DPP-4 inhibitor
Cas No.: 760937-92-6
Synonyms: 6-bromo-purinteneligliptin;3-[[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]carbonyl]thiazolidine;Methanone,[(2S,4S)-4-[4-(3-Methyl-1-phenyl-1H-pyrazol-5-yl)-1-piperazinyl]-2-pyrrolidinyl]-3-thiazolidinyl-;Teneligptin WS
Molecular Formula: C22H30N6OS
Molecular Weight: 426.58
Assay: ≥99%
Packing: Export worthy packing
Material Safety Data Sheet: Available on request
Usage: A novel DPP-4 inhibitor, treatment of Ttype 2 Diabetes